![]() |
Trials |
A Phase 2, Open-Label, Single Arm study to evaluate the safety and efficacy of Pembrolizumab in participants with recurrent or mestastatic cutanous squamous cell carcinomaCancer type: Skin cancer Phase: II Principal Investigator: Brydøy Marianne Country: NO Keywords: Norway, Bergen Status: Inclusion completed Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT03284424?term=MK3475-629&cntry=NO&rank=1 |